Johnson & Johnson (ETR:JNJ)
175.94
-2.34 (-1.31%)
Dec 22, 2025, 5:35 PM CET
Johnson & Johnson Revenue
Johnson & Johnson had revenue of $23.99B USD in the quarter ending September 28, 2025, with 6.77% growth. This brings the company's revenue in the last twelve months to $92.15B, up 5.08% year-over-year. In the year 2024, Johnson & Johnson had annual revenue of $88.82B with 4.30% growth.
Revenue (ttm)
$92.15B
Revenue Growth
+5.08%
P/S Ratio
5.39
Revenue / Employee
$667.26K
Employees
138,100
Market Cap
424.82B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 88.82B | 3.66B | 4.30% |
| Dec 31, 2023 | 85.16B | 5.17B | 6.46% |
| Jan 1, 2023 | 79.99B | 1.25B | 1.59% |
| Jan 2, 2022 | 78.74B | -3.84B | -4.65% |
| Jan 3, 2021 | 82.58B | 525.00M | 0.64% |
| Dec 29, 2019 | 82.06B | 478.00M | 0.59% |
| Dec 30, 2018 | 81.58B | 5.13B | 6.71% |
| Dec 31, 2017 | 76.45B | 4.56B | 6.34% |
| Jan 1, 2017 | 71.89B | 1.82B | 2.59% |
| Jan 3, 2016 | 70.07B | -4.26B | -5.73% |
| Dec 28, 2014 | 74.33B | 3.02B | 4.23% |
| Dec 29, 2013 | 71.31B | 4.09B | 6.08% |
| Dec 30, 2012 | 67.22B | 2.19B | 3.37% |
| Jan 1, 2012 | 65.03B | 3.44B | 5.59% |
| Jan 2, 2011 | 61.59B | -310.00M | -0.50% |
| Jan 3, 2010 | 61.90B | -1.85B | -2.90% |
| Dec 28, 2008 | 63.75B | 2.65B | 4.34% |
| Dec 30, 2007 | 61.10B | 7.77B | 14.57% |
| Dec 31, 2006 | 53.32B | 2.81B | 5.56% |
| Jan 1, 2006 | 50.51B | 3.17B | 6.69% |
| Jan 2, 2005 | 47.35B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
Johnson & Johnson News
- 14 hours ago - Rep. Thomas Kean Has Sold Up to $100K Worth Of Johnson & Johnson Stock: Here's What You Should Know - Benzinga
- 1 day ago - Johnson & Johnson hit with another giant asbestos-talcum powder verdict: $65.5 million in Minnesota - Fortune
- 2 days ago - Why a Minnesota Jury Ordered Johnson & Johnson To Pay $65.5 Million in Damages - Benzinga
- 2 days ago - Jury says Johnson & Johnson owes woman $65.5 million - NBC News
- 2 days ago - Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder - New York Post
- 3 days ago - Minnesota Jury Delivers $65.5 Million History-Making Verdict Against Johnson & Johnson - Business Wire
- 3 days ago - JNJ Today: Goldman Sachs Raises Johnson & Johnson Price Target | JNJ Stock News - GuruFocus
- 3 days ago - Johnson & Johnson (JNJ) Gains FDA Approval for New Lung Cancer Treatment - GuruFocus